Latest AI and machine learning research in allergy & immunology for healthcare professionals.
Bladder cancer is the fourth most common malignant tumor in men, with limited therapeutic biomarkers...
This paper explores how artificial intelligence (AI) is being woven into precision medicine for neur...
INTRODUCTION: A significant challenge in treating non-small cell lung cancer (NSCLC) is its inherent...
Spinal cord injury (SCI) causes multifaceted postural and motor impairments that are challenging to ...
Accurate predictions of T cell receptor (TCR) specificity remain an important open problem in immuno...
The tumor microenvironment (TME) significantly influences cancer prognosis and therapeutic outcomes,...
BACKGROUND: Atopic dermatitis (AD) is a prevalent chronic and recurrent skin condition in children. ...
HIV-1 protease inhibitors are crucial for antiviral therapies targeting acquired immunodeficiency sy...
Checkpoint inhibitors (ICIs) are key therapies for NSCLC, but current selection criteria, such as e...
In recent years,immunotherapy,particularly immune checkpoint inhibitors,has been widely used in the ...
Immunogenic cell death (ICD) has been implicated in sepsis, a condition with high mortality, through...
The increasing incidence of antimicrobial resistance is becoming a serious concern worldwide and req...
Engineered T-cell receptor (eTCR) systems rely on accurately generated T-cell receptor (TCR) sequenc...
Rickettsia is a genus of bacteria that are obligate intracellular parasites and are responsible for ...
Breast cancer is the leading cause of cancer-related mortality among women worldwide. The developmen...
Despite the STING-type-I interferon pathway playing a key role in effective anti-tumor immunity, the...
Non-small cell lung cancer (NSCLC) constitutes over 80% of lung cancer cases and remains a leading c...
Glioblastoma multiforme, one of the most malignant types of brain tumor, heavily relies on glycolyti...
Immunoglobulin G (IgG) subclasses glycosylation reflects the progression of colorectal cancer (CRC)....
INTRODUCTION: Colorectal cancer (CRC), the third most common cancer worldwide, often shows limited r...
Neoantigens have emerged as ideal targets for personalized cancer immunotherapy. We depict the pan-c...